1. Home
  2. INGN vs ALMS Comparison

INGN vs ALMS Comparison

Compare INGN & ALMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INGN
  • ALMS
  • Stock Information
  • Founded
  • INGN 2001
  • ALMS 2021
  • Country
  • INGN United States
  • ALMS United States
  • Employees
  • INGN N/A
  • ALMS N/A
  • Industry
  • INGN Industrial Specialties
  • ALMS
  • Sector
  • INGN Health Care
  • ALMS
  • Exchange
  • INGN Nasdaq
  • ALMS NYSE
  • Market Cap
  • INGN N/A
  • ALMS 402.6M
  • IPO Year
  • INGN 2014
  • ALMS 2024
  • Fundamental
  • Price
  • INGN $6.35
  • ALMS $5.32
  • Analyst Decision
  • INGN Hold
  • ALMS Strong Buy
  • Analyst Count
  • INGN 2
  • ALMS 7
  • Target Price
  • INGN $7.00
  • ALMS $28.00
  • AVG Volume (30 Days)
  • INGN 237.6K
  • ALMS 403.7K
  • Earning Date
  • INGN 05-07-2025
  • ALMS 05-19-2025
  • Dividend Yield
  • INGN N/A
  • ALMS N/A
  • EPS Growth
  • INGN N/A
  • ALMS N/A
  • EPS
  • INGN N/A
  • ALMS N/A
  • Revenue
  • INGN $339,960,000.00
  • ALMS N/A
  • Revenue This Year
  • INGN $7.20
  • ALMS N/A
  • Revenue Next Year
  • INGN $1.38
  • ALMS N/A
  • P/E Ratio
  • INGN N/A
  • ALMS N/A
  • Revenue Growth
  • INGN 5.73
  • ALMS N/A
  • 52 Week Low
  • INGN $6.40
  • ALMS $3.18
  • 52 Week High
  • INGN $13.33
  • ALMS $13.53
  • Technical
  • Relative Strength Index (RSI)
  • INGN 34.03
  • ALMS N/A
  • Support Level
  • INGN $6.89
  • ALMS N/A
  • Resistance Level
  • INGN $7.29
  • ALMS N/A
  • Average True Range (ATR)
  • INGN 0.36
  • ALMS 0.00
  • MACD
  • INGN -0.00
  • ALMS 0.00
  • Stochastic Oscillator
  • INGN 36.34
  • ALMS 0.00

About ALMS ALUMIS INC

Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.

Share on Social Networks: